Lipum at its Annual General Meeting on May 10, Carl-Johan Spak was elected as a new board member of Lipum. Carl-Johan is a senior advisor at Flerie Invest and will contribute with useful knowledge, his experience from the pharmaceutical industry and previous board assignments. BioStock talked to Carl-Johan Spak about his professional background and his expectations for the role in Lipum.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.65 SEK | +0.58% | +0.58% | +32.67% |
06-18 | Lipum AB Completes Multiple Dose Part of the Phase I Clinical Study | CI |
05-28 | Lipum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.67% | 17.34M | |
+2.87% | 94.22B | |
-4.08% | 37.76B | |
-13.85% | 32.5B | |
+73.38% | 27.75B | |
-11.50% | 16.13B | |
-0.49% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |
- Stock Market
- Equities
- LIPUM Stock
- News Lipum AB
- Lipum Elects Carl-Johan Spak as New Board Member